Genfit SA Gains 54.24%

Genfit SA (GNFT:NASDAQ) soared at $5.09, representing a gain of 54.2%. On Thu, Dec 16, 2021, GNFT:NASDAQ touched a New 2-Week High of $3.32. The stock appeared on our News Catalysts scanner on Fri, Dec 17, 2021 at 10:18 AM in the 'MISCELLANEOUS' category. From Thu, Dec 02, 2021, the stock recorded 40.00% Up Days and 18.18% Green Days

The share price of the company has been moving sideways in recent weeks.

About Genfit SA (GNFT:NASDAQ)

Genfit is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development.